Orthofix Medical (OFIX) Change in Cash (2010 - 2026)

Orthofix Medical has disclosed Change in Cash across 17 years of filings, most recently posting $35.8 million for Q1 2026.

• Quarterly Change in Cash rose 241.41% year-over-year to $35.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.4 million (up 94.96% YoY) and the FY2025 annual result came in at -$623000.0, down 101.3% from the prior year.
• Change in Cash advanced to $35.8 million in Q1 2026, from $19.2 million in the prior quarter.
• Over five years, Change in Cash peaked at $53.2 million in Q4 2024 and troughed at -$25.3 million in Q1 2025.
• A 5-year average of $1.9 million and a median of -$960000.0 in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash slumped 1032.92% — and 2025, when it surged 1477.26%.
• Tracing OFIX's Change in Cash over 5 years: stood at -$960000.0 in 2022, then jumped by 526.46% to $4.1 million in 2023, then surged by 1199.07% to $53.2 million in 2024, then slumped by 63.96% to $19.2 million in 2025, then surged by 86.53% to $35.8 million in 2026.
• Business Quant data shows OFIX's Change in Cash at $35.8 million in Q1 2026, $19.2 million in Q4 2025, and -$2.7 million in Q3 2025.